Showing results (271-280 of 315) with videos related to
Sort By:
Pageof 32
The American Journal of Medicine|March 24, 1999
Progress report: the Arizona phase III study of the effect of wheat bran fiber on recurrence of adenomatous colon polypsD L Earnest, R E Sampliner, D J Roe, et al.Gynecologic Oncology|March 1, 1995
Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervixA V Hallum, D S Alberts, S M Lippman, et al.European Journal of Cancer (Oxford, England : 1990)|August 10, 2005
Karyometry in the early detection and chemoprevention of intraepithelial lesionsJ Ranger-Moore, D S Alberts, R Montironi, et al.American Journal of Clinical Oncology|February 1, 1994
Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group studyV K Malviya, P Y Liu, R O'Toole, et al.Journal of the National Cancer Institute|October 21, 1992
Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and miceM J Xu, P M Plezia, D S Alberts, et al.Cancer Research|June 5, 2001
Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesisX C Xu, W Y Wong, L Goldberg, et al.Gynecologic Oncology|January 1, 1989
Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stage III, optimal disease ovarian cancer: a Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, R V O'Toole, et al.Gynecologic Oncology|September 10, 1999
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group studyE A Poplin, P Y Liu, J E Delmore, et al.Anti-Cancer Drugs|October 1, 1995
Phase I and pharmacokinetic study of etoposide phosphateD J Brooks, N R Srinivas, D S Alberts, et al.Investigational New Drugs|April 1, 1988
Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trialS M Lippman, J F Kessler, M Al-Sarraf, et al.Pageof 32